Infection Control in Home Care Settings: Protocols and Compliance

Infection control in home care settings encompasses the practices, regulatory standards, and procedural frameworks that govern how healthcare workers prevent, identify, and contain infectious agents when delivering care in a patient's residence. Unlike hospital environments with centralized infection prevention infrastructure, home settings present variable physical conditions, inconsistent supply availability, and reduced oversight capacity — factors that shape how federal and accreditation standards are applied. This page covers the foundational definitions, operational mechanisms, common clinical scenarios, and the decision logic used to classify and respond to infection risks across home-based care services.

Definition and scope

Infection control in home care refers to the systematic application of evidence-based practices to reduce the transmission of pathogenic microorganisms between patients, caregivers, and household contacts during the delivery of in-home health services. The scope includes skilled nursing at home, home infusion therapy, wound care at home, and home ventilator care, among other service lines — each carrying distinct infection risk profiles.

The Centers for Disease Control and Prevention (CDC) classifies infection control measures into two tiers under its Standard and Transmission-Based Precautions framework:

Medicare-certified home health agencies are subject to the Conditions of Participation (CoPs) under 42 CFR Part 484, which require agencies to maintain an active infection control program. The standard at §484.70 specifically mandates written infection control policies, employee training, and surveillance mechanisms. The Joint Commission, a major accrediting body for home health agencies, enforces its own Infection Prevention and Control (IC) chapter standards applicable to accredited organizations.

How it works

Infection control programs in home care operate through a structured cycle of risk assessment, intervention, monitoring, and corrective action. The process differs from acute care primarily in that the "environment of care" is the patient's private residence — a setting the agency does not control architecturally.

Core operational phases:

  1. Pre-visit risk stratification: Before a clinician enters the home, available clinical data (diagnosis, current infections, antibiotic history, recent hospitalization) is reviewed to determine which precaution tier applies. Patients discharged from facilities after hospitalization exceeding 48 hours carry elevated risk for healthcare-associated organisms.

  2. Hand hygiene compliance: The World Health Organization's "Five Moments for Hand Hygiene" framework — before patient contact, before aseptic procedures, after body fluid exposure, after patient contact, and after contact with the patient's surroundings — applies directly to home visits and is referenced in CDC home care guidance.

  3. PPE selection and donning/doffing: Gloves, gowns, masks, and eye protection are selected based on the anticipated exposure type. The sequence for removing PPE — gloves first, then gown, then eye protection, then mask — is standardized under CDC guidance to prevent self-contamination.

  4. Equipment handling: Reusable equipment (stethoscopes, blood pressure cuffs) must be cleaned and disinfected between patients. Single-use items must not be reprocessed. The CDC's Guidelines for Disinfection and Sterilization in Healthcare Facilities classify patient care items using the Spaulding Classification (critical, semi-critical, non-critical) to determine the required level of disinfection.

  5. Waste and sharps management: Home care workers must transport sharps containers and biohazardous waste in sealed, labeled containers. Applicable standards are set by the Occupational Safety and Health Administration (OSHA) under 29 CFR 1910.1030 (Bloodborne Pathogens Standard), which applies to all healthcare workers with reasonably anticipated exposure.

  6. Surveillance and reporting: Agencies are required to track infections identified in the home care population, identify clusters, and report notifiable conditions to local health authorities per state law. OSHA's recordkeeping rules under 29 CFR Part 1904 apply to employee occupational exposures.

Common scenarios

Wound care with confirmed MRSA: When a patient receiving wound care at home has a confirmed MRSA diagnosis, contact precautions apply. Clinicians don gloves and gown before entering the wound care area, limit equipment to dedicated patient-assigned items where feasible, and bag soiled dressings in the home before transport.

Home infusion with central venous access: Patients receiving home infusion therapy via a peripherally inserted central catheter (PICC) or implanted port face central line-associated bloodstream infection (CLABSI) risk. The CDC's Checklist for Prevention of Central Line Associated Blood Stream Infections provides a procedural framework that home infusion nurses adapt to the residential setting, emphasizing maximal sterile barrier technique during line access.

Ventilator-dependent patients: Patients on home ventilator care are at elevated risk for ventilator-associated events. While the formal ventilator-associated pneumonia (VAP) surveillance definition applies in acute care, home care agencies are expected to monitor for signs of respiratory infection and document findings per the plan of care requirements under 42 CFR §484.60.

Post-surgical wound management: Patients in home care after surgery with surgical site infections (SSIs) require assessment against the CDC/National Healthcare Safety Network (NHSN) SSI surveillance definitions, which classify SSIs as superficial incisional, deep incisional, or organ/space based on anatomical depth and clinical findings.

Decision boundaries

Infection control decision logic in home care turns on two primary axes: the route of pathogen transmission and the clinical acuity of the intervention.

Transmission route classification (per CDC Standard and Transmission-Based Precautions):

Precaution Type Transmission Route PPE Minimum Example Pathogens
Standard Contact with blood/body fluids Gloves All patients
Contact Direct/indirect contact Gloves + Gown MRSA, VRE, C. difficile
Droplet Large respiratory droplets (>5 µm) Surgical mask Influenza, pertussis
Airborne Small particle aerosols (<5 µm) N95 respirator TB, measles, varicella

Intervention acuity determines whether procedures rise to the level requiring sterile versus clean technique. Sterile technique — involving sterile gloves, drapes, and instruments — is required for central line access, catheter insertion, and certain wound irrigations. Clean technique, using non-sterile gloves and a non-sterile field, is appropriate for routine wound dressing changes on chronic wounds per clinical guidelines from the Wound, Ostomy and Continence Nurses Society (WOCN).

A critical boundary in home care infection control distinguishes agency-reportable events from patient-education responsibilities. Under the CoPs at 42 CFR §484.70(c), agencies must report infections identified in employees and document patient infections in the clinical record. Patient and caregiver education on infection prevention — hand hygiene, catheter care, dressing changes — is a separate CoP requirement under §484.60(d) and does not substitute for the agency's active surveillance obligation.

Agencies accredited by CHAP (Community Health Accreditation Partner) or The Joint Commission face additional requirements: both organizations mandate that infection control data be analyzed at defined intervals and that identified trends trigger documented corrective action plans. This creates a closed-loop quality management obligation that extends beyond individual visit compliance into aggregate agency performance — relevant to how home care quality measures are evaluated at the organizational level.

References

Explore This Site

Regulations & Safety Regulatory References Tools & Calculators Bmi Health Metrics Calculator